Related Experiment Videos
Alzheimer disease: protective factors
F Nourhashemi1, S Gillette-Guyonnet, S Andrieu
1Department of Internal Medicine and Clinical Gerontology, University Hospital, Toulouse, France.
The American Journal of Clinical Nutrition
|February 19, 2000
Summary
Alzheimer disease affects 6-8% of older adults, with increasing prevalence. Nutritional factors like vitamins and homocysteine may influence cognitive function and Alzheimer
Area of Science:
- Gerontology
- Neuroscience
- Nutritional Science
Background:
- Alzheimer disease (AD) affects 6-8% of individuals over 65, with rising prevalence.
- Oxidative stress and free radical accumulation are implicated in AD pathophysiology.
- Nutritional interventions may play a protective role in AD.
Purpose of the Study:
- To review recent studies on nutritional factors and Alzheimer disease.
- To examine the relationship between cognitive function and specific nutrient levels.
- To emphasize the need to study nutritional factors in conjunction with other AD risk variables.
Main Methods:
- Literature review of recent studies.
- Analysis of correlations between cognitive skills and serum nutrient concentrations (folate, B12, B6, homocysteine).
- Consideration of multifactorial influences on AD (genetics, estrogen, anti-inflammatory drugs, socioeconomic factors).
Main Results:
- Several studies indicate a correlation between cognitive abilities and serum levels of folate, vitamin B-12, vitamin B-6, and homocysteine.
- Nutritional status appears to be a significant factor in cognitive health.
- Further research is needed to understand the interplay of nutrition with other AD risk factors.
Conclusions:
- Nutritional factors, including specific vitamins and homocysteine levels, show potential links to cognitive function in Alzheimer disease.
- A comprehensive approach, considering genetics, hormonal status, medication use, and socioeconomic factors alongside nutrition, is crucial for understanding AD.
- Intervention strategies targeting nutritional status could impact healthcare costs associated with Alzheimer disease.